Bellerophon Therapeutics, Inc. (BLPH) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K/A
Assets
Cash and equivalents	6.9	24.7	47.6	9.9	16.6	28.8	14.2	6.3
Short-term investments						3.0	5.6	17.8
Other current assets	0.6	0.7	0.5	0.5	0.8	3.8	6.7	5.4
Total current assets	7.6	25.5	48.1	10.4	17.4	35.6	26.5	29.5
Property, plant, and equipment, net	0.0	0.1	0.2	0.3	0.7	1.0	1.4	1.8
Other fixed assets	0.2	0.2	0.2			0.1	1.5	6.7
Total assets	7.9	26.9	50.2	13.1	18.4	36.8	29.7	38.4

Accounts payable	1.2	1.2	3.7	3.1	2.8	3.9	2.8	1.6
Accrued expenses	1.3	1.7	2.3	1.7	1.0	1.4	1.1	2.2
Short-term debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other current liabilities	2.9	2.1	4.4	2.8	3.8	1.8	2.6	4.2
Total current liabilities	5.4	5.1	10.4	7.6	7.5	7.1	6.5	8.1
Other liabilities		0.2	1.6	1.9	7.0	32.3	5.2
Total liabilities	5.4	5.3	12.0	9.5	14.5	39.4	11.7	8.1

Shareholders' equity [+]	2.5	21.6	38.2	3.6	3.9	-2.6	18.0	30.3
Paid-in capital	254.5	253.8	252.6	193.3	180.3	176.2	142.2	130.9
Retained earnings	-252.1	-232.2	-214.5	-189.8	-176.5	-179.3	-124.5	-100.7
Tangible shareholders' equity	2.5	21.6	38.2	3.6	3.9	-2.6	18.0	30.3